Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_assertion type Assertion NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_head.
- NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_assertion description "[The aim of this pilot study was to determine the safety and efficacy of natural human interferon beta (nIFNbeta) plus ribavirin (RBV) in patients with chronic hepatitis C who did not respond to pegylated interferon alpha (PEG-IFN), with special emphasis on the incidence of mental disorders or refusal for fear of adverse effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_provenance.
- NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_assertion evidence source_evidence_literature NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_provenance.
- NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_assertion SIO_000772 18981624 NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_provenance.
- NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_assertion wasDerivedFrom befree-2016 NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_provenance.
- NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_assertion wasGeneratedBy ECO_0000203 NP701475.RAdjCx73IzCYfysJbsbXhgkwU7JQsdY5BEO_X4DjOAaKg130_provenance.